14th International Congress of the European Association for Veterinary Pharmacology and Toxicology (EAVPT 2018)

Topics

• Anticancer chemotherapy
• Pharmacovigilance and Veterinary Drug Toxicology
• Biotransformation and transport system of drugs
• Environmental pollution by xenobiotics used in animals
• Advances in veterinary pharmacy
• Modelling and simulation
• Toxicology of pesticides and toxins
• New biologics and immunomodulators in animal therapy
• Antimicrobials – new concepts and new tools in infectiology
• Pharmacodynamics
• Antibacterials – new therapeutics and practices to treat bacterial infections
• Drug residues
• Pharmacological control of pain and inflammation
• Antiparasitics
• Advances in pharmacotherapy of ulcer disease and asthma
• Pharmacotherapy in cardiovascular disorders in animals
• Poster sessions
• New teaching approaches in pharmacology and toxicology: general teaching
• Clinical toxicology – companion animals
• Translational medicine
• Regulatory affairs
• Pharmacotherapy of cancer in companion animals
• Drug biotransformation and transporters
• Environmental contaminants of veterinary origin
• New veterinary drug formulations
• Pharmacokinetics, modelling, PBPK, IVIVC
• Antimicrobials – PK, PK/PD, clinical efficacy in ruminants
• Biologics and immunomodulators in animals
• Pharmacodynamics general
• Clinical toxicology: farm animals
• Antimicrobials – PK, PK/PD, clinical efficacy in fish, exotic and laboratory animals
• Antimicrobials – PK, PK/PD, clinical efficacy in swine and poultry
• Antimicrobials – PK, PK/PD, clinical efficacy in horses, dogs and cats
• Advances in drug residue analysis
• Pharmacological control of pain and inflammation
• Antiparasitics
• Drugs affecting the digestive, respiratory and urinary
• Advances in pharmacotherapy of cardiovascular disorders and coagulopathies. Drugs correcting abnormal animal behaviour

Who should Attend

• Researchers and clinical practitioners in the field of veterinary pharmacology and toxicology
• Representatives of regulatory authorities and the pharmaceutical industry